LIGAND PHARMACEUTICALS INCORPORATED
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2010 | $72.1M | $75.6M | $3.3M |
| FY2011 | $104.1M | $120.6M | $7.0M |
| FY2012 | $77.8M | $104.3M | $12.4M |
| FY2013 | $55.1M | $104.7M | $11.6M |
| FY2014 | $233.6M | $258.0M | $160.2M |
| FY2015 | $226.2M | $503.1M | $97.4M |
| FY2016 | $230.7M | $601.6M | $18.8M |
| FY2017 | $252.4M | $671.0M | $20.6M |
| FY2018 | $699.9M | $1.26B | $117.2M |
| FY2019 | $727.7M | $1.49B | $71.5M |